News and Announcements
Intermin Signs Exploration Farm-in JV with Eastern Goldfields Ltd
- Published June 01, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Further to the announcement on 5 September 2016, Eastern Goldfields Limited (ASX: EGSis pleased to announce that it has signed an Exploration Farm-in Joint Venture Agreement for certain tenements at the Menzies and Goongarrie projects with Intermin Resources Limited (ASX:IRC) (Intermin) and its wholly owned subsidiary Black Mountain Gold Ltd (BMG) (Agreement).
The Tenements contain nearly 200,000 oz Au in reported resources*, with historic production in excess of 830,000 oz, primarily from underground sources. The Project areas lie approximately 50km northeast and east of the Davyhurst mill.
Executive Chairman Michael Fotios said:
“The signing of the Agreement completes the formalities of this matter. The deal has not changed from when we announced the signing of the Heads of Agreement on 5 September 2016. We are now excited by proceeding to undertake an earn in to a potential 65% interest in the Joint Venture, which may include a feasibility study into the establishment of a second mine potentially to be located in the Mt. Ida/Menzies region.
“We look forward to keeping the market informed as we progress.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
